Doseology Financial Statements From 2010 to 2025
| DOSEF Stock | USD 0.05 0.00 0.00% |
Check Doseology Sciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Doseology Sciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Doseology financial statements analysis is a perfect complement when working with Doseology Sciences Valuation or Volatility modules.
Doseology |
Doseology Sciences OTC Stock Price To Book Analysis
Doseology Sciences' Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Current Doseology Sciences Price To Book | 0.49 X |
Most of Doseology Sciences' fundamental indicators, such as Price To Book, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Doseology Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
Based on the latest financial disclosure, Doseology Sciences has a Price To Book of 0.4895 times. This is 98.09% lower than that of the Healthcare sector and 91.9% lower than that of the Biotechnology industry. The price to book for all United States stocks is 94.85% higher than that of the company.
Doseology Sciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Doseology Sciences's current stock value. Our valuation model uses many indicators to compare Doseology Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Doseology Sciences competition to find correlations between indicators driving Doseology Sciences's intrinsic value. More Info.Doseology Sciences is rated below average in current valuation category among its peers. It is rated below average in shares outstanding category among its peers creating about 95.46 of Shares Outstanding per Current Valuation. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Doseology Sciences' earnings, one of the primary drivers of an investment's value.About Doseology Sciences Financial Statements
Doseology Sciences stakeholders use historical fundamental indicators, such as Doseology Sciences' revenue or net income, to determine how well the company is positioned to perform in the future. Although Doseology Sciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Doseology Sciences' assets and liabilities are reflected in the revenues and expenses on Doseology Sciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Doseology Sciences. Please read more on our technical analysis and fundamental analysis pages.
Doseology Sciences Inc. engages in the cultivation and extraction of nutraceutical and pharmaceutical products in Canada. Doseology Sciences Inc. was incorporated in 2019 and is based in Kelowna, Canada. Doseology Sciences is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Doseology OTC Stock
Doseology Sciences financial ratios help investors to determine whether Doseology OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Doseology with respect to the benefits of owning Doseology Sciences security.